NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, UK.
Am J Sports Med. 2024 Mar;52(4):987-997. doi: 10.1177/03635465241228209. Epub 2024 Feb 26.
Despite an acute knee injury being a major risk factor for osteoarthritis, the factors that initiate and maintain this risk of longer-term knee symptoms are poorly understood. Bioactive lipids derived from omega-3 and -6 polyunsaturated fatty acids have key roles in the regulation of the inflammatory response and have been linked to joint damage and osteoarthritis pain in translational models.
There would be associations between systemic levels of bioactive lipids and knee symptoms longitudinally after an acute knee injury and related knee surgery.
Controlled laboratory study.
This study analyzed a subset of young, active adults who had sustained an acute knee injury (recruited via a surgical care pathway) and healthy age- and sex-matched controls. Surgery, if performed, was conducted after the baseline serum sample was taken and before the 3-month and 2-year visits. Liquid chromatography-tandem mass spectrometry of 41 bioactive lipids was carried out in sera of (1) 47 injured participants (median age, 28 years) collected at baseline (median, 24 days after injury), 3 months, and 2 years, along with the Knee injury and Osteoarthritis Outcome Score, and (2) age- and sex-matched controls.
Levels of the omega-3 polyunsaturated fatty acids eicosapentaenoic acid (≤ .0001) and docosahexaenoic acid (≤ .0001) and the pro-resolving lipid mediators 17- and 14-hydroxydocosahexaenoic acid, and 18-hydroxyeicosapentaenoic acid were all significantly greater at baseline in injured participants compared with the later time points and also higher than in healthy controls ( = .0019 and ≤ .0001, respectively). Levels of pro-inflammatory prostaglandins E2 and D2, leukotriene B4, and thromboxane B2 were significantly lower at baseline compared with the later time points. Higher levels of 8,9-, 11,12-, and 14,15-dihydroxyeicosatrienoic acid (DHET) were cross-sectionally associated with more severe knee pain/symptoms according to the Knee injury and Osteoarthritis Outcome Score at 2 years ( = .0004, = 0.251; = .0002, = 0.278; and = .0012, = 0.214, respectively).
The profile of pro-resolving versus pro-inflammatory lipids at baseline suggests an initial activation of pro-resolution pathways, followed by the later activation of pro-inflammatory pathways.
In this largely surgically managed cohort, the association of soluble epoxide hydrolase metabolites, the DHETs, with more severe knee symptoms at 2 years provides a rationale for further investigation into the role of this pathway in persisting knee symptoms in this population, including potential therapeutic strategies.
尽管急性膝伤是骨关节炎的一个主要危险因素,但引发和维持这种长期膝关节症状的因素仍知之甚少。源自欧米伽-3 和欧米伽-6 多不饱和脂肪酸的生物活性脂质在炎症反应的调节中起着关键作用,并且在转化模型中与关节损伤和骨关节炎疼痛有关。
在急性膝伤和相关膝关节手术后,系统中生物活性脂质的水平与膝关节症状存在纵向关联。
对照实验室研究。
本研究分析了一组年轻、活跃的成年人,他们遭受了急性膝伤(通过手术护理途径招募)和健康的年龄和性别匹配的对照组。如果进行手术,则在基线血清样本采集后进行,然后在 3 个月和 2 年就诊时进行。对 47 名受伤参与者(中位年龄 28 岁)的血清进行了 41 种生物活性脂质的液相色谱-串联质谱分析,基线时(伤后中位数 24 天)、3 个月和 2 年,同时还进行了膝关节损伤和骨关节炎结局评分(Knee injury and Osteoarthritis Outcome Score,KOOS)。
与后期时间点相比,ω-3 多不饱和脂肪酸二十碳五烯酸(eicosapentaenoic acid,EPA;≤.0001)和二十二碳六烯酸(docosahexaenoic acid,DHA;≤.0001)以及促解决脂质介质 17-和 14-羟基二十二碳六烯酸(17- and 14-hydroxydocosahexaenoic acid,17- and 14-HDHA)和 18-羟基二十碳五烯酸(18-hydroxyeicosapentaenoic acid,18-HEPE)的水平在基线时均显著较高,且也高于健康对照组(=.0019 和≤.0001)。与后期时间点相比,促炎前列腺素 E2 和 D2、白三烯 B4 和血栓素 B2 的水平在基线时显著降低。根据 2 年时的膝关节损伤和骨关节炎结局评分(Knee injury and Osteoarthritis Outcome Score,KOOS),8,9-、11,12-和 14,15-二羟基二十碳三烯酸(14,15-dihydroxyeicosatrienoic acid,14,15-DHET)的更高水平与更严重的膝关节疼痛/症状呈横断面关联(=.0004,= 0.251;=.0002,= 0.278;=.0012,= 0.214)。
基线时促解决与促炎脂质的特征提示初始促解决途径的激活,随后是促炎途径的后期激活。
在这个主要接受手术治疗的队列中,可溶性环氧化物水解酶代谢物二氢二十碳三烯酸(DHET)与 2 年后更严重的膝关节症状相关,这为进一步研究该途径在该人群中持续膝关节症状中的作用提供了依据,包括潜在的治疗策略。